| 前收市價 | 34.00 |
| 開市 | 34.00 |
| 買盤 | 32.00 |
| 賣出價 | 38.00 |
| 拍板 | 140.00 |
| 到期日 | 2025-01-17 |
| 今日波幅 | 34.00 - 34.00 |
| 合同範圍 | 無 |
| 成交量 | |
| 未平倉合約 | 40 |
InvestorPlaceGenomics Game-Changers: 3 Stocks Unlocking the Secrets of Life
Genomics is the future of medicine. With it, companies are racing to shed light on human health and disease. Over the last two decades, related studies have allowed us to create genetic risk scores. For example, millions of people can get a better idea of developing a disease based on individual genetics. Also, this is creating big opportunity for some of the best genomics stock picks. “Genomics has given us a more comprehensive understanding of genetic risk factors for complex traits (body mass
Insider MonkeyIllumina, Inc. (NASDAQ:ILMN) Q1 2024 Earnings Call Transcript
Illumina, Inc. (NASDAQ:ILMN) Q1 2024 Earnings Call Transcript May 2, 2024 Illumina, Inc. misses on earnings expectations. Reported EPS is $-0.79245 EPS, expectations were $0.03. Illumina, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, ladies and gentlemen, […]
ZacksIllumina (ILMN) Q1 Earnings Beat, Adjusted Operating Loss Widens
Illumina (ILMN) surpasses expectations in the first quarter in a challenging global macroeconomic environment.
